Eurozone business activity reaches multi-month highs, driven by strong performance in Germany's private sector.
U.S. and EU impose sweeping sanctions on Russian energy, targeting revenues, vessels, and enablers, with potential global impact on oil flows and trading.
FDA updates biosimilars guidance to streamline approvals and boost competition, aiming to cut regulatory barriers and speed lower-cost options to market.
Eurozone business activity reaches multi-month highs, driven by strong performance in Germany's private sector.
U.S. and EU impose sweeping sanctions on Russian energy, targeting revenues, vessels, and enablers, with potential global impact on oil flows and trading.
FDA updates biosimilars guidance to streamline approvals and boost competition, aiming to cut regulatory barriers and speed lower-cost options to market.